‘Dangling’ Cancer Indications In US: New Year Brings New Withdrawals Of Accelerated Approvals

 
• By Sue Sutter
  
Jenga block removal
FDA scrutiny has led to removal of accelerated approval cancer indications. • Source: Alamy

More from Clinical Trials

More from R&D